Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102

Webcast to be held on Monday, December 5th at 8:30 a.m. EST CARMIEL, Israel, Dec. 4, 2022 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic...